As evidenced by many clinical studies, patients with MetS exhibit significantly higher concentrations of TNF-α and IL-6 than subjects without MetS, confirming that inflammation has a role in the pathogenesis of this syndrome. The gene discussed is TNF; the disease is metabolic syndrome.